SIRPα is widely studied as an inhibitory receptor on macrophages, which recognizes as a ligand of the cell surface molecule CD47, expressed mainly on myeloid cells and also upregulated on cancer cells [11, 20, 21]. Here, SIRPA is linked to cancer.